The Times of IndiaHealth
Anthropic CEO predicts AI could make cancer history
Anthropic is working with biotechnology companies to speed drug discovery for cancer, food allergies and rare diseases. Its research includes T-cell therapies and antibody designs, while muscular dystrophy treatments remain preclinical and have not entered clinical trials.
This card is an AI-assisted summary of reporting published by The Times of India. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.